Rodrique Mortel

Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group Study)

Howard D. Homesley, B. Bundy, Alexander Sedlis et al. · American Journal of Obstetrics and Gynecology · 1991 · 357 citations

Vulvar Diseases, Obstetrics Staging, Gynecological Surgery +8

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.

G A Omura, B. Bundy, Jonathan S. Berek et al. · Journal of Clinical Oncology · 1989 · 327 citations

Randomized Clinical Trial, Surgical Oncology, Cancer Management +21

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease

George D. Malkasian, Robert C. Knapp, Philip T. Lavin et al. · American Journal of Obstetrics and Gynecology · 1988 · 228 citations

Urology, Preoperative Evaluation, Cervical Cancer +7

Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.

J. Lacey, Louise A. Brinton, Fatima Mohamed Abbas et al. · PubMed · 1999 · 114 citations

Contraceptive Use, Hormonal Contraceptive, Oral Contraceptive +22

Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer

George C. Lewis, Nelson H. Slack, Rodrique Mortel et al. · Gynecologic Oncology · 1974 · 104 citations

Primary Definitive Treatment, Medicine, Gynecology +7